• Disulfiram as a Proteasome Inhibitor: Precision Assay Strate

  2026-06-25

  Explore how Disulfiram, a dopamine β-hydroxylase inhibitor, unlocks advanced assay design and targeted apoptosis induction for cancer research. This article delivers a fresh, protocol-focused perspective, linking mechanistic insights to practical workflow innovation.

• Proteinase K: Broad-Spectrum Serine Protease in DNA Prep

  2026-06-25

  Proteinase K is a broad-spectrum serine protease widely used for protein hydrolysis and the removal of enzyme contaminants during genomic DNA isolation. Its robust activity, inhibitor resistance, and compatibility with diverse conditions make it a gold standard for DNA integrity preservation in molecular biology workflows.

• Trifluoperazine 2HCl: Optimizing Dopamine D2 Inhibitor Assay

  2026-06-24

  Trifluoperazine 2HCl stands out as a robust dopamine D2 receptor inhibitor, enabling high-fidelity modulation in neuropharmacology and immunology assays. This article distills actionable workflows and troubleshooting strategies, bridging dopaminergic signaling studies with emerging metabolic research insights.

• 7ACC2: Monocarboxylate Transporter 1 Inhibitor for Tumor Met

  2026-06-23

  7ACC2 is a dual-action monocarboxylate transporter 1 inhibitor that disrupts both lactate and pyruvate transport, providing a precise tool for dissecting tumor metabolic vulnerabilities. Its nanomolar potency and proven tumor growth delay in preclinical models make it indispensable in advanced cancer metabolism and immunometabolism research.

• Perphenazine Beyond Psychosis: Mechanistic Innovations for H

  2026-06-23

  Explore Perphenazine as a dopamine D2 receptor antagonist with emerging roles in mitochondria-mediated cell death and host-pathogen research. This article uncovers methodologically actionable insights for scientists investigating neuropharmacology and host-directed antibacterial strategies.

• Perphenazine (SKU B6157): Reliable Dopamine Antagonist in La

  2026-06-22

  This article addresses real-world laboratory challenges in cell viability, cytotoxicity, and immune modulation assays, highlighting how Perphenazine (SKU B6157) from APExBIO offers reproducible, data-backed solutions. Emphasis is placed on its quantitative performance, protocol compatibility, and vendor reliability, ensuring researchers achieve consistent and interpretable results in complex neuropharmacology and immunology workflows.

• Testosterone Bounce as a Prognostic Biomarker in Prostate Ca

  2026-06-22

  This study identifies testosterone bounce (T bounce) as a robust prognostic biomarker for overall and cancer-specific survival in prostate cancer patients undergoing degarelix acetate therapy. The findings provide a framework for integrating dynamic testosterone monitoring into clinical decision-making, highlighting the evolving role of hormone-level kinetics in cancer prognosis.

• Puromycin Aminonucleoside for Precision Podocyte Injury Mode

  2026-06-21

  Puromycin aminonucleoside is the gold-standard reagent for inducing nephrotic injury and modeling focal segmental glomerulosclerosis (FSGS) with robust translational relevance. This guide synthesizes protocol best practices, advanced troubleshooting, and new insights from mechanistic studies to help researchers optimize podocyte injury workflows using APExBIO’s trusted product.

• Perphenazine: Dopamine D2 Receptor Antagonist in Modern Rese

  2026-06-20

  Perphenazine's unique dopamine D2 receptor antagonist profile empowers both neuropharmacology and host-directed antibacterial workflows. This guide translates cutting-edge findings into actionable protocols, troubleshooting strategies, and advanced applications for maximizing research impact.

• METTL17-Mediated Ferroptosis Resistance in Colorectal Cancer

  2026-06-19

  This study identifies the mitochondrial protein METTL17 as a critical regulator of ferroptosis resistance and tumorigenesis in colorectal cancer, acting via modulation of mitochondrial RNA methylation and translation. The findings provide mechanistic insights into mitochondrial defense systems and highlight METTL17 as a promising therapeutic target for sensitizing tumors to ferroptosis-based interventions.

• Applied ddhCTP: Workflow Optimization for RNA Virus Inhibiti

  2026-06-19

  ddhCTP (3ʹ-deoxy-3′,4ʹ-didehydro-CTP) enables precision antiviral research by directly interrupting viral RNA synthesis in both classical and advanced cellular models. This guide translates mechanistic insights and published protocols into actionable workflows and troubleshooting strategies for robust, reproducible RNA virus inhibition.

• Streptavidin-Cy3: Advanced Biotin Detection for Metastasis R

  2026-06-18

  Streptavidin-Cy3 unlocks ultra-bright, reliable biotin detection across immunohistochemistry, immunofluorescence, and flow cytometry, enabling deep mechanistic studies of cancer metastasis. This guide translates cutting-edge use-cases and troubleshooting strategies into actionable protocols for translational research teams.

• 3D-Tumor Spheroid Assay for Glioblastoma Stemness Detection

  2026-06-18

  This study introduces a streamlined 3D-tumor spheroid assay for rapidly assessing stemness in glioblastoma cell lines, reducing assay time and resource use. The protocol enables reproducible evaluation of glioma stem-like cell behavior, aiding drug screening and mechanistic studies in tumor biology.

• DHHC9-STRN4 Palmitoylation Axis: A Target in YAP-Driven Meta

  2026-06-17

  This study uncovers DHHC9-mediated S-palmitoylation of STRN4 as a critical driver of YAP-dependent cancer metastasis. Pharmacological inhibition of DHHC9 disrupts this pathway, providing a novel mechanistic target for intervention in metastatic adenocarcinoma.

• Cy7 NHS Ester: Protocols for Near-Infrared Protein Labeling

  2026-06-17

  Cy7 NHS ester is a sulfonated, water-soluble near-infrared dye optimized for labeling amino groups in proteins and peptides, especially in workflows sensitive to denaturation or requiring minimal fluorescence quenching. It is ideal for researchers needing reproducible, gentle labeling in aqueous environments for in vitro and in vivo imaging but is not suited for protocols reliant on long-term dye solution stability or exclusively organic solvents.

445 records 13/30 page Previous Next First page 上5页 1112131415 下5页 Last page